Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Cutaneous T-cell lymphoma refractory
ADR ID BADD_A09754
ADR Hierarchy
01      Blood and lymphatic system disorders
01.11      Lymphomas non-Hodgkin's T-cell
01.11.03      Mycoses fungoides
01.11.03.004      Cutaneous T-cell lymphoma refractory
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.17      Lymphomas non-Hodgkin's T-cell
16.17.03      Mycoses fungoides
16.17.03.004      Cutaneous T-cell lymphoma refractory
23      Skin and subcutaneous tissue disorders
23.07      Skin and subcutaneous tissue disorders NEC
23.07.04      Skin and subcutaneous conditions NEC
23.07.04.031      Cutaneous T-cell lymphoma refractory
Description Not Available
MedDRA Code 10011679
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cerebriform T lymphoma (Lukes-Collins Classification) refractory | Cutaneous T-cell lymphoma refractory | Mycosis fungoides (Working Formulation) refractory | Mycosis fungoides refractory | Mycosis fungoides/Sezary syndrome refractory | Sezary syndrome refractory | Sezary's disease refractory | Sezary's syndrome refractory | Small cell cerebriform (Mycosis fungoides sezary syndrome) (Kiel Classification) refractory
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01359Mechlorethamine0.000112%
The 1th Page    1    Total 1 Pages